Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
S
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.76% |
| 2 | Technology | 16.41% |
| 3 | Consumer Staples | 10.58% |
| 4 | Consumer Discretionary | 10.13% |
| 5 | Communication Services | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PBPB
1751
DELISTED
Potbelly
PBPB
| $4.21M | ﹤0.01% |
1,846,695
+19,600
| +1% | +$53.7K |
|
1752
Vanguard Short-Term Bond ETF
BSV
$45.7B
| $4.2M | ﹤0.01% |
50,502
-64,298
| -56% | -$5.32M |
|
1753
Host Hotels & Resorts
HST
$15.7B
| $4.2M | ﹤0.01% |
388,865
-511,179
| -57% | -$5.87M |
|
1754
Conagra Brands
CAG
$7.5B
| $4.18M | ﹤0.01% |
118,981
+63,181
| +113% | +$2.11M |
|
1755
First Bancorp
FNLC
$402M
| $4.18M | ﹤0.01% |
192,595
-25,005
| -11% | -$515K |
|
1756
Donaldson
DCI
$11.1B
| $4.17M | ﹤0.01% |
+89,600
| New | +$3.96M |
|
1757
Orrstown Financial Services
ORRF
$852M
| $4.17M | ﹤0.01% |
282,399
-1,477
| -0.5% | -$19.7K |
|
1758
Banco Macro
BMA
$4.96B
| $4.13M | ﹤0.01% |
222,497
+128,797
| +137% | +$2.38M |
|
|
ESGR
1759
DELISTED
Enstar Group
ESGR
| $4.13M | ﹤0.01% |
27,000
-10,100
| -27% | -$1.49M |
|
|
CFMS
1760
DELISTED
Conformis, Inc. Common Stock
CFMS
| $4.12M | ﹤0.01% |
201,168
-9,442
| -4% | -$197K |
|
|
AKCA
1761
DELISTED
Akcea Therapeutics Inc
AKCA
| $4.12M | ﹤0.01% |
300,504
+266,104
| +774% | +$4.11M |
|
1762
Hovnanian Enterprises
HOV
$785M
| $4.12M | ﹤0.01% |
175,915
-35,700
| -17% | -$540K |
|
1763
Comscore
SCOR
$93.6M
| $4.11M | ﹤0.01% |
66,362
-2,500
| -4% | -$150K |
|
|
ECOL
1764
DELISTED
US Ecology, Inc.
ECOL
| $4.11M | ﹤0.01% |
121,306
-78,900
| -39% | -$2.57M |
|
|
FARM
1765
DELISTED
Farmer Brothers
FARM
| $4.1M | ﹤0.01% |
558,500
+26,100
| +5% | +$210K |
|
|
PW
1766
Power REIT
PW
$2.94M
| $4.1M | ﹤0.01% |
14,250
+3,130
| +28% | +$616K |
|
1767
State Street SPDR Nuveen ICE Municipal Bond ETF
TFI
$3.17B
| $4.09M | ﹤0.01% |
79,200
+74,000
| +1,423% | +$3.77M |
|
1768
SmartFinancial
SMBK
$902M
| $4.09M | ﹤0.01% |
252,574
-30,200
| -11% | -$441K |
|
1769
Belden
BDC
$5.31B
| $4.08M | ﹤0.01% |
125,500
+52,607
| +72% | +$1.75M |
|
|
PTLA
1770
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $4.08M | ﹤0.01% |
226,500
-712,497
| -76% | -$9.91M |
|
|
PWOD
1771
DELISTED
Penns Woods Bancorp
PWOD
| $4.07M | ﹤0.01% |
179,102
-2,400
| -1% | -$53.6K |
|
1772
Prothena Corp
PRTA
$455M
| $4.06M | ﹤0.01% |
387,962
+303,062
| +357% | +$3.37M |
|
1773
RH
RH
$3.44B
| $4.06M | ﹤0.01% |
16,300
-1,258,879
| -99% | -$228M |
|
|
VOXX
1774
DELISTED
VOXX International Corporation Class A
VOXX
| $4.06M | ﹤0.01% |
701,720
+138,398
| +25% | +$688K |
|
1775
ARK Innovation ETF
ARKK
$6.42B
| $4.05M | ﹤0.01% |
56,800
+47,100
| +486% | +$2.76M |
|
Similar funds
Jim Simons's Q2 2020 Portfolio in Review
As of Q2 2020, Jim Simons held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Jim Simons withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,366 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 26% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Jim Simons opened a new position in Uber worth $187M.
- Jim Simons's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Jim Simons added most to Zoom in Q2 2020, an estimated $806M increase.
- Jim Simons's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Jim Simons fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Jim Simons's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Jim Simons opened 584 new positions and closed 596 in Q2 2020.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.